Recent Updates
Recently added Catalysts

F2 filter and delivery system

Phase 1

Aortic Stenosis | Unknown | Cardiovascular |Encompass Health Corporation|Trials Updated: Oct 30, 2026

F2 filter and delivery system development status

Highest phase Phase 1
Registered trials 3 across 1 sponsor since May 2023

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLED
Total Trials1
Total Enrollment31

FDA Designations

No designations recorded

F2 filter and delivery system clinical trials

F2 filter and delivery system · 1 trial · 1 indication

Phase 1 1
NCT05866640Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRAortic Stenosis
COMPLETED31 Analytics
PHASE1COMPLETED
Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Aortic Stenosis
NCT0586664031
Unlock trial analytics

Study Endpoints

Primary Endpoints

Major adverse cardiac and cerebrovascular events
30 days

Secondary Endpoints

New lesions
8-72 hours
Performance
intra-procedure
Modified Rankin Scale
30 day
Unlock Study Endpoints

Study Design & Arms

AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeDEVICE_FEASIBILITY

Treatment Arms

ArmTypeDescription
InterventionEXPERIMENTALPlacement of the F2 device in the aorta to cover the great cerebral vessels.

Interventions

NameTypeDescription
F2 filter and delivery systemDEVICEPlacement of F2 device in aorta to cover great cerebral vessels
Unlock Study Design Details

Eligibility Criteria

Age Range22 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: criteria: 1. Age ≥ 22 years. 2. The patient meets the established criteria and indications for commercially available TAVR (Edwards/Medtronic) for transfemoral access. 3. Montreal Cognitive Assessment (MoCA) score ≥ 26 at screening. 4. The patient is willing and able to comply ...

Countries:Georgia
Unlock Eligibility Criteria

Explore more on BiopharmaWatch

Encompass Health Corporation (EHC)Pipeline, catalysts, financials, insiders and newsBiotech disease mapWho is developing what in each indication, and how crowded it isFDA calendarUpcoming PDUFA dates, AdComs and approval oddsPDUFA calendarEvery scheduled FDA decision date, month by monthHistorical FDA calendarPast decisions and how the stock moved on eachCatalyst SyncUpcoming readouts and decisions, screened by runway and phaseBiotech stock screenerFilter by clinical phase, cash runway and market capDrugs A to ZEvery drug page starting with FCompanies A to ZEvery biotech and pharma company we track